Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Overview Rating
Speculative
Amgen (NASDAQ:AMGN) Stock Quotes, Forecast and News Summary
Amgen Stock (NASDAQ: AMGN) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Amgen (AMGN) stock?
You can purchase shares of Amgen (NASDAQ:AMGN) through any online brokerage.
Who are Amgen (AMGN) competitors?
Other companies in Amgen’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and United Therapeutics (NASDAQ:UTHR).
What is the forecast, or price target, for Amgen (AMGN) stock?
Amgen has a consensus price target of $311.30.
What is the current price for Amgen (AMGN)?
The stock price for Amgen (NASDAQ: AMGN) is $287.6 last updated November 21, 2024 at 9:31 AM EST.
Does Amgen (AMGN) pay a dividend?
A quarterly cash dividend of 2.25 per share of Class A Common Stock. The quarterly cash dividend was payable on December 9, 2024 to stockholders of record on November 18, 2024.
When is Amgen (NASDAQ:AMGN) reporting earnings?
Amgen’s Q4 earnings are confirmed for Tuesday, February 4, 2025.
Is Amgen (AMGN) going to split?
There is no upcoming split for Amgen.
What sector and industry does Amgen (AMGN) operate in?
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.